Why the study?
Platelets play a substantial role in thromboembolic complications and have increased activity in rheumatic mitral stenosis, but the utility of platelet indices to predict restenosis after PMBV needed evaluation.
Do platelet indices predict mitral restenosis in patients who underwent percutaneous mitral balloon valvuloplasty?
Do platelet indices predict mitral restenosis in patients who underwent percutaneous mitral balloon valvuloplasty?
This study aims to determine whether platelet indices can serve as useful predictors of mitral restenosis following percutaneous mitral balloon valvuloplasty.
Answers are grounded in this paper and cite their sources.
Platelet indices may warrant monitoring after PMBV; leaves open their value as restenosis predictors pending prospective validation.
Objectives: Percutaneous mitral balloon valvuloplasty (PMBV) has been established as an effective and safe treatment modality for symptomatic patients with severe rheumatic mitral stenosis. Wilkin scores 8 are associated with higher rates of procedural success and lower rates of restenosis. It is well-known that platelets have a substantial role in thromboembolic complications of rheumatic mitral stenosis and various studies have showed that increases platelet (PLT) activity in rheumatic mitral stenosis. The aim of this study was to assess the usefulness of PLT indices as a predictor of restenosis in patients who underwent PMBV.
No takes yet. Share an insight, caveat, or question.
Taşbulak et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: